Arab Israeli Conflict
Middle East News
Hi Tech News
Mylan rejected Teva's $41 billion bid earlier this week.
Acquisition would create leading company with potential to transform global market for generics.
Teva sought stay of lower court ruling that favored developers of generic versions of its top selling multiple sclerosis drug.
Deal will further enhance Teva’s goals of delivering the highest quality medicines at the most competitive prices, Israeli company says.
By NIV ELIS,REUTERS
The newly-approved preventive migraine drug could bring in as much as $500 million in sales annually.
By EYTAN HALON
Les scientifiques israéliens sont à l’avant-garde de la guerre contre « la pire des maladies». Tour d’horizon des dernières percées dans le domaine de la recherche
By SHLOMO MAITAL
C’est la course contre la montre pour sauver l’entreprise Teva et la lourde tâche en incombe à Erez Vigodman, son nouveau PDG, sur le pied de guerre
Small, medium local authorities out-perform large cities in waste separation.
By SHARON UDASIN
Agreement will allow Teva to save millions of dollars each year by switching from expensive, polluting fuel oil and LPG to natural gas.
While claiming to be acting in the interest of Israel’s workers, facts are stubborn things, and the Histadrut’s fingerprints are all over an Israeli society that is being hobbled by a skyrocketing cost of living.
BY Gidon Ben-Zvi
Claims against Teva focused on the branded opioid products Actiq and Fentora as well as generic painkillers it produced.
Teva has reduced its spending by $2.5 billion since initiating the restructuring last year.
An EpiPen, or epinephrine auto-injector, is a medication used to treat serious allergic reactions in emergencies.
By YVETTE J. DEANE
Please insert a valid email address